Hobart L Rogers

Hobart L Rogers

National Center for Toxicological Research - - / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4458424
-
person_outline Hobart L Rogers's MOST POPULAR ARTICLES
1-) A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failureHL Rogers, J Marshall, J Bock, TC Dowling, E Feller, S Robinson, ...Journal of cardiac failure 14 (1), 1-5, 20081382008
2-) The U.S. Food and Drug Administration\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical TrialAG Durmowicz, R Lim, H Rogers, CJ Rosebraugh, BA ChowdhuryAnnals of the American Thoracic Society 15 (1), 1-2, 2018822018
3-) Allopurinol pharmacogenetics: assessment of potential clinical usefulnessI Zineh, P Mummaneni, J Lyndly, S Amur, LA La Grenade, SH Chang, ...Pharmacogenomics 12 (12), 1741-1749, 2011512011
4-) CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the US Food and Drug Administration\'s new dosing recommendationsHL Rogers, A Bhattaram, I Zineh, J Gobburu, M Mathis, TP Laughren, ...The Journal of clinical psychiatry 73 (9), 4005, 2012502012
5-) Consistency of drug–drug and gene–drug interaction information in US FDA-approved drug labelsDJ Conrado, HL Rogers, I Zineh, MA PacanowskiPharmacogenomics 14 (2), 215-223, 2013422013